US Stock MarketDetailed Quotes

SANA Sana Biotechnology

Watchlist
  • 2.550
  • +0.100+4.08%
Close Nov 27 16:00 ET
569.34MMarket Cap-1821P/E (TTM)

Sana Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.46%-51.82M
0.44%-58.54M
17.21%-65.63M
12.57%-253.58M
31.69%-51.96M
1.92%-63.55M
17.74%-58.8M
-2.01%-79.27M
-15.53%-290.05M
30.91%-76.07M
Net income from continuing operations
-6,189.84%-59.92M
55.88%-50.29M
-30.87%-107.48M
-5.11%-283.26M
-9.54%-88.12M
101.16%984K
-57.32%-114M
-161.14%-82.12M
24.29%-269.48M
27.35%-80.44M
Depreciation and amortization
-9.82%4.06M
-12.43%3.9M
-13.81%3.75M
57.16%24.56M
168.51%11.26M
12.03%4.5M
17.05%4.45M
20.25%4.35M
41.15%15.63M
25.79%4.2M
Other non cash items
92.34%-6.38M
-196.17%-25.87M
6,400.18%36.47M
40.27%-49.03M
239.34%6.72M
-1,323.42%-83.21M
256.96%26.91M
101.03%561K
-233.15%-82.08M
43.13%-4.82M
Change In working capital
-106.64%-344K
-83.22%2.35M
30.96%-7.46M
146.76%18.61M
283.32%10.24M
-57.12%5.18M
216.89%14M
-221.54%-10.81M
-23.05%7.54M
-263.57%-5.59M
-Change in prepaid assets
413.64%678K
-191.78%-5.08M
-2,145.28%-2.38M
235.99%8.14M
139.39%2.58M
-89.23%132K
118.39%5.53M
96.68%-106K
-595.47%-5.99M
-408.71%-6.56M
-Change in payables and accrued expense
-127.22%-1.19M
-17.19%5.81M
-1.80%-10.89M
-104.10%-491K
-217.96%-1.17M
-53.49%4.36M
227.01%7.01M
-1,872.88%-10.69M
114.71%11.97M
126.63%991K
-Change in other working capital
-75.91%165K
11.71%1.62M
72,650.00%5.8M
601.60%10.96M
40,236.36%8.83M
-53.50%685K
656.32%1.45M
-102.15%-8K
-69.30%1.56M
-136.67%-22K
Cash from discontinued investing activities
Operating cash flow
18.46%-51.82M
0.44%-58.54M
17.21%-65.63M
12.57%-253.58M
31.69%-51.96M
1.92%-63.55M
17.74%-58.8M
-2.01%-79.27M
-15.53%-290.05M
30.91%-76.07M
Investing cash flow
Cash flow from continuing investing activities
-18.64%41.78M
-86.35%5.82M
-223.12%-77.23M
-18.31%172.01M
-82.69%15.31M
61.17%51.35M
-45.16%42.63M
400.02%62.73M
185.66%210.56M
220.05%88.43M
Net PPE purchase and sale
-83.30%-4.09M
-727.90%-13.06M
-628.17%-15.85M
4.04%-20.03M
-205.22%-14.05M
48.67%-2.23M
64.09%-1.58M
71.11%-2.18M
30.09%-20.88M
11.53%-4.6M
Net investment purchase and sale
-14.40%45.87M
-57.30%18.87M
-194.58%-61.38M
-17.02%192.04M
-68.44%29.36M
47.98%53.58M
-46.17%44.2M
223.25%64.9M
209.50%231.44M
245.62%93.03M
Cash from discontinued investing activities
Investing cash flow
-18.64%41.78M
-86.35%5.82M
-223.12%-77.23M
-18.31%172.01M
-82.69%15.31M
61.17%51.35M
-45.16%42.63M
400.02%62.73M
185.66%210.56M
220.05%88.43M
Financing cash flow
Cash flow from continuing financing activities
1,013.37%2.08M
-63.98%10.63M
78,881.78%186.4M
544.13%31.65M
61.92%1.72M
-88.46%187K
1,768.59%29.51M
-63.80%236K
-99.22%4.91M
-65.98%1.06M
Net common stock issuance
-480.00%-29K
-101.63%-439K
--181.47M
544.13%31.65M
337.04%4.64M
-100.31%-5K
1,610.83%27.01M
--0
-99.22%4.91M
-80.15%1.06M
Proceeds from stock option exercised by employees
909.90%1.94M
38.02%3.44M
1,988.56%4.93M
----
----
--192K
--2.49M
--236K
----
----
Net other financing activities
--172K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,013.37%2.08M
-63.98%10.63M
78,881.78%186.4M
544.13%31.65M
61.92%1.72M
-88.46%187K
1,768.59%29.51M
-63.80%236K
-99.22%4.91M
-65.98%1.06M
Net cash flow
Beginning cash position
-24.69%138.79M
5.80%180.89M
-26.66%137.35M
-28.48%187.27M
-0.90%172.28M
-10.17%184.3M
-13.36%170.96M
-28.48%187.27M
106.26%261.85M
-60.71%173.85M
Current changes in cash
33.73%-7.96M
-415.78%-42.1M
366.95%43.54M
33.06%-49.92M
-360.25%-34.93M
61.63%-12.02M
70.23%13.33M
74.72%-16.31M
-155.28%-74.58M
107.43%13.42M
End cash Position
-24.06%130.83M
-24.69%138.79M
5.80%180.89M
-26.66%137.35M
-26.66%137.35M
-0.90%172.28M
-10.17%184.3M
-13.36%170.96M
-28.48%187.27M
-28.48%187.27M
Free cash flow
15.01%-55.91M
-18.58%-71.6M
-0.04%-81.48M
12.00%-273.61M
18.18%-66.01M
4.86%-65.78M
20.42%-60.38M
4.45%-81.45M
-10.68%-310.93M
30.04%-80.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.46%-51.82M0.44%-58.54M17.21%-65.63M12.57%-253.58M31.69%-51.96M1.92%-63.55M17.74%-58.8M-2.01%-79.27M-15.53%-290.05M30.91%-76.07M
Net income from continuing operations -6,189.84%-59.92M55.88%-50.29M-30.87%-107.48M-5.11%-283.26M-9.54%-88.12M101.16%984K-57.32%-114M-161.14%-82.12M24.29%-269.48M27.35%-80.44M
Depreciation and amortization -9.82%4.06M-12.43%3.9M-13.81%3.75M57.16%24.56M168.51%11.26M12.03%4.5M17.05%4.45M20.25%4.35M41.15%15.63M25.79%4.2M
Other non cash items 92.34%-6.38M-196.17%-25.87M6,400.18%36.47M40.27%-49.03M239.34%6.72M-1,323.42%-83.21M256.96%26.91M101.03%561K-233.15%-82.08M43.13%-4.82M
Change In working capital -106.64%-344K-83.22%2.35M30.96%-7.46M146.76%18.61M283.32%10.24M-57.12%5.18M216.89%14M-221.54%-10.81M-23.05%7.54M-263.57%-5.59M
-Change in prepaid assets 413.64%678K-191.78%-5.08M-2,145.28%-2.38M235.99%8.14M139.39%2.58M-89.23%132K118.39%5.53M96.68%-106K-595.47%-5.99M-408.71%-6.56M
-Change in payables and accrued expense -127.22%-1.19M-17.19%5.81M-1.80%-10.89M-104.10%-491K-217.96%-1.17M-53.49%4.36M227.01%7.01M-1,872.88%-10.69M114.71%11.97M126.63%991K
-Change in other working capital -75.91%165K11.71%1.62M72,650.00%5.8M601.60%10.96M40,236.36%8.83M-53.50%685K656.32%1.45M-102.15%-8K-69.30%1.56M-136.67%-22K
Cash from discontinued investing activities
Operating cash flow 18.46%-51.82M0.44%-58.54M17.21%-65.63M12.57%-253.58M31.69%-51.96M1.92%-63.55M17.74%-58.8M-2.01%-79.27M-15.53%-290.05M30.91%-76.07M
Investing cash flow
Cash flow from continuing investing activities -18.64%41.78M-86.35%5.82M-223.12%-77.23M-18.31%172.01M-82.69%15.31M61.17%51.35M-45.16%42.63M400.02%62.73M185.66%210.56M220.05%88.43M
Net PPE purchase and sale -83.30%-4.09M-727.90%-13.06M-628.17%-15.85M4.04%-20.03M-205.22%-14.05M48.67%-2.23M64.09%-1.58M71.11%-2.18M30.09%-20.88M11.53%-4.6M
Net investment purchase and sale -14.40%45.87M-57.30%18.87M-194.58%-61.38M-17.02%192.04M-68.44%29.36M47.98%53.58M-46.17%44.2M223.25%64.9M209.50%231.44M245.62%93.03M
Cash from discontinued investing activities
Investing cash flow -18.64%41.78M-86.35%5.82M-223.12%-77.23M-18.31%172.01M-82.69%15.31M61.17%51.35M-45.16%42.63M400.02%62.73M185.66%210.56M220.05%88.43M
Financing cash flow
Cash flow from continuing financing activities 1,013.37%2.08M-63.98%10.63M78,881.78%186.4M544.13%31.65M61.92%1.72M-88.46%187K1,768.59%29.51M-63.80%236K-99.22%4.91M-65.98%1.06M
Net common stock issuance -480.00%-29K-101.63%-439K--181.47M544.13%31.65M337.04%4.64M-100.31%-5K1,610.83%27.01M--0-99.22%4.91M-80.15%1.06M
Proceeds from stock option exercised by employees 909.90%1.94M38.02%3.44M1,988.56%4.93M----------192K--2.49M--236K--------
Net other financing activities --172K------------------------------------
Cash from discontinued financing activities
Financing cash flow 1,013.37%2.08M-63.98%10.63M78,881.78%186.4M544.13%31.65M61.92%1.72M-88.46%187K1,768.59%29.51M-63.80%236K-99.22%4.91M-65.98%1.06M
Net cash flow
Beginning cash position -24.69%138.79M5.80%180.89M-26.66%137.35M-28.48%187.27M-0.90%172.28M-10.17%184.3M-13.36%170.96M-28.48%187.27M106.26%261.85M-60.71%173.85M
Current changes in cash 33.73%-7.96M-415.78%-42.1M366.95%43.54M33.06%-49.92M-360.25%-34.93M61.63%-12.02M70.23%13.33M74.72%-16.31M-155.28%-74.58M107.43%13.42M
End cash Position -24.06%130.83M-24.69%138.79M5.80%180.89M-26.66%137.35M-26.66%137.35M-0.90%172.28M-10.17%184.3M-13.36%170.96M-28.48%187.27M-28.48%187.27M
Free cash flow 15.01%-55.91M-18.58%-71.6M-0.04%-81.48M12.00%-273.61M18.18%-66.01M4.86%-65.78M20.42%-60.38M4.45%-81.45M-10.68%-310.93M30.04%-80.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data